Novel Pathogenic Variants in PJVK, the Gene Encoding Pejvakin, in Subjects with Autosomal Recessive Non-Syndromic Hearing Impairment and Auditory Neuropathy Spectrum Disorder

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fullext

    Forlagets udgivne version, 1,2 MB, PDF-dokument

  • María Domínguez-Ruiz
  • Montserrat Rodríguez-Ballesteros
  • Marta Gandía
  • Elena Gómez-Rosas
  • Manuela Villamar
  • Pietro Scimemi
  • Patrizia Mancini
  • Nanna D. Rendtorff
  • Miguel A. Moreno-Pelayo
  • Tranebjærg, Lisbeth
  • Carme Medà
  • Rosamaria Santarelli
  • Ignacio Del Castillo

Pathogenic variants in the PJVK gene cause the DFNB59 type of autosomal recessive non-syndromic hearing impairment (AR-NSHI). Phenotypes are not homogeneous, as a few subjects show auditory neuropathy spectrum disorder (ANSD), while others show cochlear hearing loss. The numbers of reported cases and pathogenic variants are still small to establish accurate genotype-phenotype correlations. We investigated a cohort of 77 Spanish familial cases of AR-NSHI, in whom DFNB1 had been excluded, and a cohort of 84 simplex cases with isolated ANSD in whom OTOF variants had been excluded. All seven exons and exon-intron boundaries of the PJVK gene were sequenced. We report three novel DFNB59 cases, one from the AR-NSHI cohort and two from the ANSD cohort, with stable, severe to profound NSHI. Two of the subjects received unilateral cochlear implantation, with apparent good outcomes. Our study expands the spectrum of PJVK mutations, as we report four novel pathogenic variants: p.Leu224Arg, p.His294Ilefs*43, p.His294Asp and p.Phe317Serfs*20. We review the reported cases of DFNB59, summarize the clinical features of this rare subtype of AR-NSHI and discuss the involvement of PJVK in ANSD.

OriginalsprogEngelsk
Artikelnummer149
TidsskriftGenes
Vol/bind13
Udgave nummer1
ISSN2073-4425
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
This research was funded by the Instituto de Salud Carlos III (ISCIII), Madrid, Spain, National Plan for Scientific and Technical Research and Innovation 2013?2016, with cofounding from the European Regional Development Fund, ?A way to make Europe?) (to I.d.C.), grant number PI17/00572; by the Regional Government of Madrid (to M.A.M-P.), grant number S2017/ BMD3721; and by the ?Department of Excellence 2018?2022? initiative of the Italian Ministry of Education (MIUR) awarded to the Department of Neurosciences, University of Padua.

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

ID: 290538466